Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Diabetes medicine (FOI)

Diabetes medicine (FOI)

Produced by the Freedom of Information office
Authored by Government of Jersey and published on 03 March 2020.
Prepared internally, no external costs.

​Request

Can you please advise the following for a diabetes medicine called Ozempic (semaglutide):

A

Has funding been approved for GPs and Hospitals to prescribe semaglutide?

B

What is semaglutide's Red, Amber, Green (RAG) formulary status?

C

Is semaglutide positioned as 1, 2, 3 or 4th line GLP-1 on formulary (within it's RAG status)?

D

If semaglutide is approved for funding, what is date it was approved?

Response

A

Semaglutide is approved for prescribing by both GPs and the hospital.

B

Green.

C

Semaglutide is not positioned in relation to other GLP-1 (glucagon-like peptide 1) medicines. The decision on which one to prescribe is left to the clinical discretion of the prescriber.

D

Semaglutide was approved for prescribing in the hospital in April 2019 and for prescribing by GPs on 1 November 2019.

Our sites
Back to top
rating button